UPC outlines next steps in Sanofi's prostate cancer drug dispute
MLex Summary: The Unified Patent Court’s Munich division has issued a procedural order in Sanofi’s ongoing litigation over European patent 2,493,466, covering a prostate cancer treatment. The order addresses formal issues in...To view the full article, register now.
Already a subscriber? Click here to view full article